{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:17:11Z","timestamp":1790741831255,"version":"4.1.0"},"reference-count":93,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["U01CK000633"],"award-info":[{"award-number":["U01CK000633"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["U01CK000175"],"award-info":[{"award-number":["U01CK000175"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Claflin Distinguished Scholars Award"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pre-travel health interventions can reduce the acquisition of communicable diseases and decrease the risk of transmission during or after international travel. We sought to inform policy and research priorities with a scoping literature review of studies that assess the cost-effectiveness of pre-travel interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We assessed 44 economic evaluation studies published from 1946\u20132023, regarding pre-travel prevention of hepatitis A, hepatitis B, influenza, malaria, rabies, travellers\u2019 diarrhoea, cholera, polio, typhoid fever, measles, and Japanese encephalitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Published studies demonstrate that hepatitis A vaccination, malaria chemoprophylaxis and typhoid vaccination for people travelling to highly endemic settings are likely to be cost-effective, as is measles-mumps-rubella vaccination. The cost-effectiveness of other pre-travel interventions is more sensitive to travel frequency and duration, endemicity at the travel destination, travel purpose (e.g. business, leisure, visiting friends and relatives), risk perceptions (e.g. adherence to care plan, choosing to vaccinate), and costs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Cost-effectiveness analyses of pre-travel interventions can inform the value of such interventions, but such analyses depend on the availability of high-quality data regarding clinical outcomes and costs. We propose that international, collaborative networks should collect data and leverage novel technologies to expand the evidence base regarding the risks of exposure, clinical outcomes, risk perception, and costs associated with pre-travel interventions. This evidence base can inform recommendations for specific groups of travellers and the formulation of population-specific health policies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jtm\/taaf053","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T07:42:18Z","timestamp":1750750938000},"source":"Crossref","is-referenced-by-count":5,"title":["Economic value of pre-travel health interventions for communicable diseases in international travellers"],"prefix":"10.1093","volume":"32","author":[{"given":"Tijana","family":"Stanic","sequence":"first","affiliation":[{"name":"Medical Practice Evaluation Center, Massachusetts General Hospital , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Koiso","sequence":"additional","affiliation":[{"name":"Medical Practice Evaluation Center, Massachusetts General Hospital , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi F","family":"Fields","sequence":"additional","affiliation":[{"name":"Medical Practice Evaluation Center, Massachusetts General Hospital , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison Taylor","family":"Walker","sequence":"additional","affiliation":[{"name":"Division of Global Migration and Quarantine, Centers for Disease Control and Prevention , Atlanta, GA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora M","family":"Mulroy","sequence":"additional","affiliation":[{"name":"Medical Practice Evaluation Center, Massachusetts General Hospital , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward T","family":"Ryan","sequence":"additional","affiliation":[{"name":"Traveler\u2019s Advice and Immunization Center, Massachusetts General Hospital , Boston, MA ,","place":["USA"]},{"name":"Division of Infectious Diseases, Massachusetts General Hospital , Boston, MA ,","place":["USA"]},{"name":"Harvard Medical School , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina C","family":"LaRocque","sequence":"additional","affiliation":[{"name":"Traveler\u2019s Advice and Immunization Center, Massachusetts General Hospital , Boston, MA ,","place":["USA"]},{"name":"Division of Infectious Diseases, Massachusetts General Hospital , Boston, MA ,","place":["USA"]},{"name":"Harvard Medical School , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily P","family":"Hyle","sequence":"additional","affiliation":[{"name":"Medical Practice Evaluation Center, Massachusetts General Hospital , Boston, MA ,","place":["USA"]},{"name":"Traveler\u2019s Advice and Immunization Center, Massachusetts General Hospital , Boston, MA ,","place":["USA"]},{"name":"Division of Infectious Diseases, Massachusetts General Hospital , Boston, MA ,","place":["USA"]},{"name":"Harvard Medical School , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"key":"2025112323464263800_ref1","doi-asserted-by":"publisher","DOI":"10.18111\/9789284425808","volume-title":"International Tourism Highlights","author":"World Tourism Organization (UN Tourism)","year":"2024"},{"key":"2025112323464263800_ref2","volume-title":"International Tourism, Number of Arrivals.","author":"The World Bank Group"},{"key":"2025112323464263800_ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09669582.2020.1758708","article-title":"Pandemics, tourism and global change: a rapid assessment of COVID-19","volume":"29","author":"G\u00f6ssling","year":"2021","journal-title":"J Sustain Tour"},{"key":"2025112323464263800_ref4","volume-title":"The World of Air Transport in 2022","author":"The International Civil Aviation Organization"},{"key":"2025112323464263800_ref5","doi-asserted-by":"publisher","DOI":"10.18111\/9789284423200","volume-title":"The Economic Contribution of Tourism and the Impact of COVID-19","author":"World Tourism Organization","year":"2021"},{"key":"2025112323464263800_ref6","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780197570944.001.0001","volume-title":"CDC Yellow Book 2024: Health Information for International Travel","author":"Centers for Disease Control and Prevention","year":"2023"},{"key":"2025112323464263800_ref7","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"2025112323464263800_ref8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccc.2011.10.002","article-title":"Health economic methods: cost-minimization, cost-effectiveness, cost-utility, and cost-benefit evaluations","volume":"28","author":"Higgins","year":"2012","journal-title":"Crit Care Clin"},{"key":"2025112323464263800_ref9","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1136\/bmj.318.7194.1349","article-title":"Types of economic evaluation","volume":"318","author":"Palmer","year":"1999","journal-title":"BMJ"},{"key":"2025112323464263800_ref10","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"key":"2025112323464263800_ref11","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/0264-410X(92)90554-W","article-title":"Cost-effectiveness analysis of hepatitis a prevention in travellers","volume":"10","author":"Tormans","year":"1992","journal-title":"Vaccine"},{"key":"2025112323464263800_ref12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archinte.1994.00420060093010","article-title":"Testing for antibody to hepatitis a to decrease the cost of hepatitis a prophylaxis with immune globulin or hepatitis a vaccines","volume":"154","author":"Bryan","year":"1994","journal-title":"Arch Intern Med"},{"key":"2025112323464263800_ref13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/jmv.1890440429","article-title":"Cost-effectiveness analysis of vaccination against hepatitis a in travellers","volume":"44","author":"Van Doorslaer","year":"1994","journal-title":"J Med Virol"},{"key":"2025112323464263800_ref14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1708-8305.1994.tb00579.x","article-title":"Recommendations for prevention of hepatitis a based on a cost-effectiveness analysis","volume":"1","author":"Tormans","year":"1994","journal-title":"J Travel Med"},{"key":"2025112323464263800_ref15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2165\/00019053-199508010-00007","article-title":"Cost effectiveness of hepatitis a prevention in France","volume":"8","author":"Severo","year":"1995","journal-title":"Pharmacoeconomics"},{"key":"2025112323464263800_ref16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00019053-199712030-00008","article-title":"Cost effectiveness of hepatitis a virus immunisation in Spain","volume":"12","author":"Arnal","year":"1997","journal-title":"Pharmacoeconomics"},{"key":"2025112323464263800_ref17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0163-4453(98)92910-3","article-title":"An economic evaluation of vaccination against hepatitis a for frequent travellers","volume":"36","author":"Fenn","year":"1998","journal-title":"J Infect"},{"key":"2025112323464263800_ref18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2310\/7060.2002.21957","article-title":"Empiric immunization versus serologic screening: developing a cost-effective strategy for the use of hepatitis a immunization in travelers","volume":"9","author":"Fishbain","year":"2002","journal-title":"J Travel Med"},{"key":"2025112323464263800_ref19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/ije\/27.1.118","article-title":"The prevalence of hepatitis a antibodies among Israeli travellers and the economic feasibility of screening before vaccination","volume":"27","author":"Schwartz","year":"1998","journal-title":"Int J Epidemiol"},{"key":"2025112323464263800_ref20","first-page":"541","article-title":"The prevalence and direct costs of pre-immunization testing for hepatitis a in general practice","volume":"46","author":"Buckley","year":"1996","journal-title":"Br J Gen Pract"},{"key":"2025112323464263800_ref21","first-page":"1379","article-title":"Should British soldiers be vaccinated against hepatitis a?","volume":"12","author":"Jefferson","year":"1994","journal-title":"An economic analysis Vaccine"},{"key":"2025112323464263800_ref22","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.vaccine.2019.01.070","article-title":"Economic evaluation of a publicly funded hepatitis a travel vaccination program in Ontario","volume":"37","author":"Ramsay","year":"2019","journal-title":"Canada Vaccine"},{"key":"2025112323464263800_ref23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1708-8305.2009.00320.x","article-title":"Vaccination strategies against hepatitis a in travelers older than 40 years: an economic evaluation","volume":"16","author":"Costas","year":"2009","journal-title":"J Travel Med"},{"key":"2025112323464263800_ref24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1017\/S0950268801005969","article-title":"Cost analysis of two strategies for preventing hepatitis a virus infection in Spanish travellers to developing countries","volume":"127","author":"Bayas","year":"2001","journal-title":"Epidemiol Infect"},{"key":"2025112323464263800_ref25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ewjm.173.5.325","article-title":"Screening travelers for hepatitis a antibodies: an observational cost-comparison study of vaccine use","volume":"173","author":"Lee","year":"2000","journal-title":"West J Med"},{"key":"2025112323464263800_ref26","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1017\/S026646230000670X","article-title":"An economic evaluation of the introduction of vaccination against hepatitis a in a peacekeeping operation. The case of the United Nations protection force in Yugoslavia","volume":"10","author":"Jefferson","year":"1994","journal-title":"Int J Technol Assess Health Care"},{"key":"2025112323464263800_ref27","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1016\/j.vaccine.2013.05.014","article-title":"Cost-effectiveness of hepatitis B vaccination using HEPLISAV\u2122 in selected adult populations compared to Engerix-B\u00ae vaccine","volume":"31","author":"Kuan","year":"2013","journal-title":"Vaccine"},{"key":"2025112323464263800_ref28","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0033-3549(04)50291-1","article-title":"An economic assessment of pre-vaccination screening for hepatitis a and B","volume":"118","author":"Jacobs","year":"2003","journal-title":"Public Health Rep"},{"key":"2025112323464263800_ref29","first-page":"36","article-title":"Maritime health: a case for preventing influenza on the high seas","volume":"53","author":"Ruben","year":"2002","journal-title":"Int Marit Health"},{"key":"2025112323464263800_ref30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.healthpol.2008.03.002","article-title":"Reimbursement of malaria chemoprophylaxis for travellers from Europe to sub-Saharan Africa: cost-effectiveness analysis from the perspective of the French national health insurance system","volume":"88","author":"Pistone","year":"2008","journal-title":"Health Policy"},{"key":"2025112323464263800_ref31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/1471-2334-10-279","article-title":"Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa","volume":"10","author":"Widmer","year":"2010","journal-title":"BMC Infect Dis"},{"key":"2025112323464263800_ref32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1475-2875-10-130","article-title":"Cost risk benefit analysis to support chemoprophylaxis policy for travellers to malaria endemic countries","volume":"10","author":"Massad","year":"2011","journal-title":"Malar J"},{"key":"2025112323464263800_ref33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/cid\/cit570","article-title":"Economics of malaria prevention in US travelers to West Africa","volume":"58","author":"Adachi","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2025112323464263800_ref34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0264-410X(95)00110-M","article-title":"Pre-exposure rabies prophylaxis for the international traveller: a decision analysis","volume":"14","author":"LeGuerrier","year":"1996","journal-title":"Vaccine"},{"key":"2025112323464263800_ref35","first-page":"25","article-title":"Rabies vaccination strategies in the Netherlands in 2018: a cost evaluation","volume":"25","author":"Suijkerbuijk","journal-title":"Euro Surveill"},{"key":"2025112323464263800_ref36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1708-8305.2008.00270.x","article-title":"Cost-benefit of WC\/rBS oral cholera vaccine for vaccination against ETEC-caused travelers\u2019 diarrhea","volume":"16","author":"Lundkvist","year":"2009","journal-title":"J Travel Med"},{"key":"2025112323464263800_ref37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-2334-9-65","article-title":"Effectiveness and economic analysis of the whole cell\/recombinant B subunit (WC\/rbs) inactivated oral cholera vaccine in the prevention of traveller\u2019s diarrhea","volume":"9","author":"L\u00f3pez-Gigosos","year":"2009","journal-title":"BMC Infect Dis"},{"key":"2025112323464263800_ref38","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1016\/j.vaccine.2014.07.070","article-title":"Relative cost-effectiveness of a norovirus vaccine in the deployed military setting compared to a vaccine against campylobacter sp., ETEC, and Shigella sp","volume":"32","author":"Tallant","year":"2014","journal-title":"Vaccine"},{"key":"2025112323464263800_ref39","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1016\/j.vaccine.2017.05.090","article-title":"Modeling the costs and benefits of temporary recommendations for poliovirus exporting countries to vaccinate international travelers","volume":"35","author":"Duintjer Tebbens","year":"2017","journal-title":"Vaccine"},{"key":"2025112323464263800_ref40","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1469-0691.2004.00901.x","article-title":"Vaccination against typhoid fever in travellers: a cost-effectiveness approach","volume":"10","author":"Papadimitropoulos","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"2025112323464263800_ref41","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/cid\/ciy861","article-title":"The clinical impact and cost-effectiveness of measles-mumps-rubella vaccination to prevent measles importations among international travelers from the United States","volume":"69","author":"Hyle","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2025112323464263800_ref42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/JOM.0000000000001474","article-title":"Analysis of the full economic cost for Japanese encephalitis under different risk scenarios for business travelers to Asia","volume":"61","author":"Rogers","year":"2019","journal-title":"J Occup Environ Med"},{"key":"2025112323464263800_ref43","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1016\/j.vaccine.2020.02.032","article-title":"Comparative economic analysis of strategies for Japanese encephalitis vaccination of U.S. travelers","volume":"38","author":"Carias","year":"2020","journal-title":"Vaccine"},{"key":"2025112323464263800_ref44","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/bmj.309.6959.918","article-title":"Is travel prophylaxis worth while? Economic appraisal of prophylactic measures against malaria, hepatitis a, and typhoid in travellers","volume":"309","author":"Behrens","year":"1994","journal-title":"BMJ"},{"key":"2025112323464263800_ref45","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/jpids\/piac011","article-title":"The clinical and economic impact of measles-mumps-rubella vaccinations to prevent measles importations from US pediatric travelers returning from abroad","volume":"11","author":"Bangs","year":"2022","journal-title":"Journal of the Pediatric Infectious Diseases Society"},{"key":"2025112323464263800_ref46","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.idnow.2022.06.004","article-title":"Should anti-malarial chemoprophylaxis be reimbursed in France? A cost-effectiveness analysis of different reimbursement strategies","volume":"52","author":"Fiorina","year":"2022","journal-title":"Infect Dis Now"},{"key":"2025112323464263800_ref47","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/j.vaccine.2008.03.008","article-title":"Development of a travelers\u2019 diarrhea vaccine for the military: how much is an ounce of prevention really worth?","volume":"26","author":"Riddle","year":"2008","journal-title":"Vaccine"},{"key":"2025112323464263800_ref48","first-page":"1947","article-title":"Cholera vaccination: a decision analysis","volume":"146","author":"MacPherson","year":"1992","journal-title":"CMAJ"},{"key":"2025112323464263800_ref49","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/archinte.1988.00380110071015","article-title":"A cost-effectiveness comparison of the use of antimicrobial agents for treatment or prophylaxis of travelers\u2019 diarrhea","volume":"148","author":"Reves","year":"1988","journal-title":"Arch Intern Med"},{"key":"2025112323464263800_ref50","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.4269\/ajtmh.17-0196","article-title":"Strategies to improve management of acute watery diarrhea during a military deployment: a cost effectiveness analysis","volume":"97","author":"Schrader","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"2025112323464263800_ref51","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1016\/j.vaccine.2021.05.020","article-title":"Comparative cost-effectiveness of a 2-dose versus 3-dose vaccine for hepatitis B prevention in selected adult populations","volume":"39","author":"Hirst","year":"2021","journal-title":"Vaccine"},{"key":"2025112323464263800_ref52","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0264-410X(91)90221-Q","article-title":"Pre-exposure rabies prophylaxis for travellers: are the benefits worth the cost?","volume":"9","author":"Bernard","year":"1991","journal-title":"Vaccine"},{"key":"2025112323464263800_ref53","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/milmed\/163.8.564","article-title":"An economic evaluation of hepatitis a vaccination in Dutch military personnel","volume":"163","author":"Buma","year":"1998","journal-title":"Mil Med"},{"key":"2025112323464263800_ref54","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2165\/00019053-199610050-00005","article-title":"A cost-effectiveness analysis of typhoid fever vaccines in US military personnel","volume":"10","author":"Warren","year":"1996","journal-title":"Pharmacoeconomics"},{"key":"2025112323464263800_ref55","first-page":"1","article-title":"Prevention of hepatitis a through active or passive immunization: recommendations of the advisory committee on immunization practices (ACIP)","volume":"55","author":"Fiore","year":"2006","journal-title":"MMWR"},{"key":"2025112323464263800_ref56","volume-title":"Control of Neglected Tropical Diseases","author":"The World Health Organization"},{"key":"2025112323464263800_ref57","volume-title":"The Pretravel Consultation","author":"Centers for Disease Control and Prevention","year":", :   , 2023."},{"key":"2025112323464263800_ref58","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/heapol\/czw177","article-title":"Infectious disease risk and international tourism demand","volume":"32","author":"Rossell\u00f3","year":"2017","journal-title":"Health Policy Plan"},{"key":"2025112323464263800_ref59","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2105\/AJPH.2009.178335","article-title":"Epidemiology and burden of hepatitis a, malaria, and typhoid in new York City associated with travel: implications for public health policy","volume":"100","author":"Adamson","year":"2010","journal-title":"Am J Public Health"},{"key":"2025112323464263800_ref60","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/cid\/ciaa070","article-title":"A review of measles outbreak cost estimates from the United States in the postelimination era (2004-2017): estimates by perspective and cost type","volume":"71","author":"Pike","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025112323464263800_ref61","volume-title":"WHO Immunization Data Portal. Measles Reported Cases and Incidence","author":"The World Health Organization"},{"key":"2025112323464263800_ref62","doi-asserted-by":"crossref","first-page":"e0239385","DOI":"10.1371\/journal.pone.0239385","article-title":"Multiple drivers of the COVID-19 spread: the roles of climate, international mobility, and region-specific conditions","volume":"15","author":"Kubota","year":"2020","journal-title":"PloS One"},{"key":"2025112323464263800_ref63","volume-title":"Cholera Vaccines.","author":"Centers for Disease Control and Prevention","year":"2024"},{"key":"2025112323464263800_ref64","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40794-018-0074-4","article-title":"A review of antibiotic prophylaxis for traveler\u2019s diarrhea: past to present","volume":"4","author":"Diptyanusa","year":"2018","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"2025112323464263800_ref65","doi-asserted-by":"crossref","first-page":"taac086","DOI":"10.1093\/jtm\/taac086","article-title":"Travel-associated extensively drug-resistant typhoid fever: a case series to inform management in non-endemic regions","volume":"30","author":"Posen","year":"2023","journal-title":"J Travel Med"},{"key":"2025112323464263800_ref66","volume-title":"Epidemiological Update Yellow Fever","author":"Pan American Health Organization","year":"2019"},{"key":"2025112323464263800_ref67","doi-asserted-by":"crossref","first-page":"780","DOI":"10.15585\/mmwr.mm6629a4","article-title":"Update: temporary total depletion of U.S. licensed yellow fever vaccine for civilian travelers addressed by investigational new drug use of imported stamaril vaccine","volume":"66","author":"Gershman","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025112323464263800_ref68","volume-title":"Return of US Licensed Yellow Fever Vaccine (YF-VAX) to the Market","author":"Centers for Disease Control and Prevention","year":"2011"},{"key":"2025112323464263800_ref69","volume-title":"Yellow Fever Vaccine","author":"Centers for Disease Control and Prevention","year":"2021"},{"key":"2025112323464263800_ref70","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/QCO.0b013e32834a1aef","article-title":"Health recommendations for international travel: a review of the evidence base of travel medicine","volume":"24","author":"LaRocque","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"2025112323464263800_ref71","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/cid\/cir839","article-title":"Global TravEpiNet: a National Consortium of clinics providing care to international Travelers\u2014analysis of demographic characteristics, travel destinations, and Pretravel healthcare of high-risk US international Travelers, 2009\u20132011","volume":"54","author":"LaRocque","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2025112323464263800_ref72","doi-asserted-by":"crossref","first-page":"taaa219","DOI":"10.1093\/jtm\/taaa219","article-title":"GeoSentinel: past, present and future\u2020","volume":"27","author":"Hamer","year":"2020","journal-title":"J Travel Med"},{"key":"2025112323464263800_ref73","doi-asserted-by":"crossref","first-page":"e194515","DOI":"10.1001\/jamapediatrics.2019.4515","article-title":"Clinical practices for measles-mumps-rubella vaccination among US pediatric international travelers","volume":"174","author":"Hyle","year":"2020","journal-title":"JAMA Pediatr"},{"key":"2025112323464263800_ref74","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1473-3099(22)00651-X","article-title":"Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel network: a cross-sectional study","volume":"23","author":"Angelo","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2025112323464263800_ref75","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/QCO.0000000000000751","article-title":"Antimicrobial-resistant bacteria in international travelers","volume":"34","author":"Sridhar","year":"2021","journal-title":"Curr Opin Infect Dis"},{"key":"2025112323464263800_ref76","doi-asserted-by":"crossref","first-page":"e083065","DOI":"10.1136\/bmjopen-2023-083065","article-title":"Surveillance of global, travel-related illness using a novel app: a multivariable, cross-sectional study","volume":"14","author":"Lovey","year":"2024","journal-title":"BMJ Open"},{"key":"2025112323464263800_ref77","doi-asserted-by":"crossref","first-page":"tay034","DOI":"10.1093\/jtm\/tay034","article-title":"Real-time incidence of travel-related symptoms through a smartphone-based app remote monitoring system: a pilot study","volume":"25","author":"Rodriguez-Valero","year":"2018","journal-title":"J Travel Med"},{"key":"2025112323464263800_ref78","doi-asserted-by":"crossref","first-page":"taae074","DOI":"10.1093\/jtm\/taae074","article-title":"Usefulness of aircraft and airport wastewater for monitoring multiple pathogens including SARS-CoV-2 variants","volume":"31","author":"Tay","year":"2024","journal-title":"J Travel Med"},{"key":"2025112323464263800_ref79","doi-asserted-by":"crossref","first-page":"210","DOI":"10.15585\/mmwr.mm7208a3","article-title":"Notes from the field: aircraft wastewater surveillance for early detection of SARS-CoV-2 variants \u2014 John F. Kennedy international airport, new York City, august\u2013September 2022","volume":"72","author":"Morfino","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025112323464263800_ref80","doi-asserted-by":"crossref","first-page":"taad089","DOI":"10.1093\/jtm\/taad089","article-title":"Knowledge, attitudes and practices regarding the use of mobile travel health apps","volume":"31","author":"Machoko","year":"2024","journal-title":"J Travel Med"},{"key":"2025112323464263800_ref81","doi-asserted-by":"crossref","first-page":"taae054","DOI":"10.1093\/jtm\/taae054","article-title":"MALrisk: a machine-learning\u2013based tool to predict imported malaria in returned travellers with fever","volume":"31","author":"Balerdi-Sarasola","year":"2024","journal-title":"J Travel Med"},{"key":"2025112323464263800_ref82","doi-asserted-by":"crossref","first-page":"taac009","DOI":"10.1093\/jtm\/taac009","article-title":"Using social media listening and data mining to understand travellers\u2019 perspectives on travel disease risks and vaccine-related attitudes and behaviours","volume":"29","author":"Bravo","year":"2022","journal-title":"J Travel Med"},{"key":"2025112323464263800_ref83","doi-asserted-by":"crossref","first-page":"taae113","DOI":"10.1093\/jtm\/taae113","article-title":"Streamlining malaria prevention recommendations for travellers: current and future approaches","volume":"31","author":"McGuinness","year":"2024","journal-title":"J Travel Med"},{"key":"2025112323464263800_ref84","doi-asserted-by":"crossref","first-page":"taad113","DOI":"10.1093\/jtm\/taad113","article-title":"A decision support tool for risk\u2013benefit analysis of Japanese encephalitis vaccine in travellers","volume":"30","author":"Lau","year":"2023","journal-title":"J Travel Med"},{"key":"2025112323464263800_ref85","doi-asserted-by":"crossref","first-page":"taad056","DOI":"10.1093\/jtm\/taad056","article-title":"Pre-travel vaccine information needs, attitudes, drivers of uptake and the role for decision aids in travel medicine","volume":"30","author":"McGuinness","year":"2023","journal-title":"J Travel Med"},{"key":"2025112323464263800_ref86","doi-asserted-by":"crossref","first-page":"taac046","DOI":"10.1093\/jtm\/taac046","article-title":"A country classification system to inform rabies prevention guidelines and regulations","volume":"29","author":"Henry","year":"2022","journal-title":"J Travel Med"},{"key":"2025112323464263800_ref87","doi-asserted-by":"crossref","first-page":"taad085","DOI":"10.1093\/jtm\/taad085","article-title":"Travel vaccines\u2014priorities determined by incidence and impact","volume":"30","author":"Steffen","year":"2023","journal-title":"J Travel Med"},{"key":"2025112323464263800_ref88","doi-asserted-by":"crossref","first-page":"e2020027037","DOI":"10.1542\/peds.2020-027037","article-title":"Societal costs of a measles outbreak","volume":"147","author":"Pike","year":"2021","journal-title":"Pediatrics"},{"key":"2025112323464263800_ref89","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.15585\/mmwr.mm7146a1","article-title":"Measles, mumps, rubella vaccine (PRIORIX): recommendations of the advisory committee on immunization practices \u2014 United States, 2022","volume":"71","author":"Krow-Lucal","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025112323464263800_ref90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7305a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices \u2014 United States, 2024\u201325 influenza season","volume":"73","author":"Grohskopf","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"2025112323464263800_ref91","doi-asserted-by":"crossref","first-page":"619","DOI":"10.15585\/mmwr.mm7118a2","article-title":"Use of a modified Preexposure prophylaxis vaccination schedule to prevent human rabies: recommendations of the advisory committee on immunization practices - United States, 2022","volume":"71","author":"Rao","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025112323464263800_ref92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6802a1","article-title":"Japanese encephalitis vaccine: recommendations of the advisory committee on immunization practices","volume":"68","author":"Hills","year":"2019","journal-title":"MMWR Recomm Rep"},{"key":"2025112323464263800_ref93","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1086\/508782","article-title":"The practice of travel medicine: guidelines by the Infectious Diseases Society of America","volume":"43","author":"Hill","year":"2006","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Travel Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jtm\/advance-article-pdf\/doi\/10.1093\/jtm\/taaf053\/63565675\/taaf053.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jtm\/article-pdf\/32\/7\/taaf053\/63565675\/taaf053.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jtm\/article-pdf\/32\/7\/taaf053\/63565675\/taaf053.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T04:47:03Z","timestamp":1763959623000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jtm\/article\/doi\/10.1093\/jtm\/taaf053\/8172464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":93,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,6,26]]},"published-print":{"date-parts":[[2025,11,23]]}},"URL":"https:\/\/doi.org\/10.1093\/jtm\/taaf053","relation":{},"ISSN":["1195-1982","1708-8305"],"issn-type":[{"value":"1195-1982","type":"print"},{"value":"1708-8305","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,6,26]]},"article-number":"taaf053"}}